GXAINasdaqServices-Prepackaged SoftwareUS GAAP · USD

Gaxos.ai Inc

GAXOS.AI INC. is a U.S.-based software and services company that combines digital health, telehealth-adjacent support services, and early-stage consumer software/gaming initiatives. Its current revenue base is dominated by RNK Health, which provides non-clinical services to support patient care, alongside smaller streams from health coaching packages, subscriptions, and in-app game items.

Kysy yhtiöstä
Liikevaihto1,9milj. USD
+47 901,7 %v/v
Liikevoitto (EBIT)−4,9milj. USD
−32,7 %v/v
EBIT-marginaali−254,3%
+91 715,0 %-yks.v/v
Nettotulos−3,9milj. USD
−14,1 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2022–2025

−6−4−202milj. USD2022: EBIT −1,4 milj. USD20222024: 0,00 milj. USD2024: EBIT −3,7 milj. USD20242025: 1,9 milj. USD2025: EBIT −4,9 milj. USD20251,9−4,9
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Non-clinical healthcare support services92 %

Administrative and support services delivered through RNK Health to assist patient care workflows.

Health coaching packages2 %

Packages combining lab tests and personal health coaching sessions sold to customers.

Subscription services8 %

Recurring digital subscriptions tied to the company's software and consumer platform offerings.

In-app digital goods0 %

Small-scale sales of in-app game items within the company's consumer software products.

Game and software development rights0 %

Publishing and distribution rights obtained from third-party developers for finished titles and software.

Tuotteet

Raportoitu · osuus liikevaihdosta
78,2%21,8%FY2025100 %
  • Administrative Service78,2 %
  • Sale of Subscriptions21,8 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

The company sells primarily to healthcare-related customers and users of its RNK Health-supported services, with a smaller base of consumers buying health coaching packages and digital subscriptions. It also has a nascent consumer software/gaming audience purchasing in-app items, while third-party developers are part of the supply side rather than the customer side. Revenue concentration suggests the business currently depends on a limited set of healthcare service relationships and early-stage product adoption.

Healthcare support service customers

Buy non-clinical support services through RNK Health because they need operational assistance around patient care delivery.

Health coaching consumers

Buy lab-test-and-coaching packages for wellness guidance and personalized health support.

Digital subscribers

Pay for subscription services tied to the company's software and platform offerings.

In-app game users

Purchase small digital items within the company's games and consumer software products.

Strategia

Management is focused on building revenue scale while funding product development and maintaining liquidity through equity financing. Near term, the company is relying on RNK Health and related healthcare services, while longer term it wants to add features, expand monetization, and develop new technologies that can support recurring revenue. The strategy is still execution-heavy and capital-dependent, with success tied to user growth, regulatory compliance, and the ability to convert early usage into paid demand.

Grow RNK Health revenueLyhyt aikaväli

Current revenue is concentrated in non-clinical patient care support, so scaling this line is essential to fund the business.

Monetize the user base with new featuresKeskipitkä aikaväli

Management expects to charge fees for added features once it reaches critical mass, creating a path to recurring digital revenue.

Fund product development and operationsLyhyt aikaväli

The company expects continued operating losses and needs capital to support R&D and public-company costs.

Maantiede

The company is headquartered in the United States and its disclosed revenue base is tied to U.S. operations and customers. RNK Health's medical partner supports patients in all 50 states, so regulatory and operating exposure is primarily domestic rather than international. Because the business is still small and early-stage, geography matters more for state-by-state telehealth compliance than for cross-border expansion.

Riskit

The biggest company-specific risk is dependence on RNK Health's telehealth-related partner structure, which is exposed to changing state laws, enforcement actions, and legal challenges. The business also remains loss-making and capital dependent, so execution risk is high if revenue growth does not outpace overhead and development spending. More broadly, early-stage software and digital health models face product adoption risk, regulatory uncertainty, and impairment risk on capitalized software and intangible assets.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Telehealth regulatory and legal risk1Dependence on a third-party medical partner2
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Telehealth regulatory and legal riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    RNK Health relies on a medical partner operating under evolving state telehealth rules, which can change service availability and compliance costs.

    Kohdistuu: All 50 states through the medical partner arrangement

  2. Dependence on a third-party medical partnerVaikutus: KorkeaTodennäköisyys: Kohtalainen

    If the partner cannot provide services, the company may lose the ability to sell its core healthcare-related offering.

    Kohdistuu: RNK Health revenue stream

  3. Liquidity and financing riskVaikutus: Korkea

    The company expects operating losses and says it may need additional debt or equity financing to sustain operations.

    KohdistuuCorporate overheadR&DPublic company costs
  4. Product adoption riskVaikutus: Keskitaso

    Future monetization depends on reaching critical mass of users before charging for new features.

    Kohdistuu: Subscription and consumer software initiatives

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition across mixed offerings

Service revenue, coaching packages, subscriptions, and in-app items may be recognized at different points in time or over time.

Vaikutus: Affects quarterly revenue mix and comparability

Intangible asset impairment

Software licenses, technology licenses, and software are subject to recoverability testing and fair value judgments.

Vaikutus: Could create non-cash write-downs if expected cash flows weaken

Stock-based compensation

Equity awards and option expense can materially influence operating expenses in a small company.

Vaikutus: Affects reported losses and expense growth

Capitalized internal-use software development costs

Development-stage software spending may be capitalized or expensed depending on project stage.

Vaikutus: Changes EBITDA-like expense timing and asset balances

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

RadNet, Inc.

RDNT · Services-Medical Laboratories

Maximus, Inc

MMS · Services-Business Services, NEC

VASO Corp

VASO · Electromedical & Electrotherapeutic Apparatus

Mobile-health Network Solutions

MNDR · Services-Prepackaged Software

Lunai Bioworks Inc.

LNAI · Pharmaceutical Preparations

MedWellAI, Inc.

MWAI · Finance Services

Päivitetty: 24.9.2026

Gaxos.ai Inc (Nasdaq) – Services-Prepackaged Software | Analyysi – Clarifo